Neil Palmisiano was named the new deputy director of phase I therapeutics for hematologic malignancies and co-medical director of the Office of Human Research Services at Rutgers Cancer Institute; and new system leader for Leukemia for RWJBarnabas Health.
Christian Hinrichs, co-director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence and chief of the Section of Cancer Immunotherapy, RWJBarnabas Health, has been awarded a four-year, $800,000 translational research grant from the V Foundation for Cancer Research to develop next-generation immunotherapies for cancers caused by human papillomavirus.
